Cytotoxicity of Receptor-Mediated 16α[125I]Iodo-estradiol in Cultured MCF-7 Human Breast Cancer Cells

Therapeutic strategies using 125I-labeled steroid hormones are attractive in light of the estrogen dependence of many human breast cancers and the favorable microdosimetry resulting from 125I decay. We determined the uptake, specific estrogen receptor (ER) binding, and cytotoxicity of 16α-[125.I]iod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 1989-03, Vol.81 (6), p.437-440
Hauptverfasser: McLaughlin, W. H., Milius, R. A., Pillai, K. M. R., Edasery, J. P., Blumenthal, R. D., Bloomer, W. D.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Therapeutic strategies using 125I-labeled steroid hormones are attractive in light of the estrogen dependence of many human breast cancers and the favorable microdosimetry resulting from 125I decay. We determined the uptake, specific estrogen receptor (ER) binding, and cytotoxicity of 16α-[125.I]iodoestradiol in cultured MCF-7 human breast cancer cells. The cytotoxicity of receptor-mediated 125I appears to be sufficient in MCF-7 cells to warrant in vivo experimentation. Furthermore, cytotoxicity not specific to ERs is minimal within the dose range necessary for ER saturation and specific cell killing. Competitive toxicity studies using nonradioactive 17β-estradiol demonstrate an unequivocal relationship between ER binding and clonogenic viability. [J Natl Cancer Inst 81:437–440, 1989]
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/81.6.437